Clinical Trials Browser

Vaccine-Preventable Diseases, COVID-19, Vaccination Hesitancy, Influenza, Human, Patient Acceptance of Health Care, Colorectal Neoplasms, Health Behavior

NCT04080531 2025-02-28

Influenza Vaccination for Flu Prevention in Patients With Plasma Cell Disorders

Phase 4 Completed

165 enrolled 9 charts

Plasma cell

Neoplasms, Plasma Cell

NCT02860039 2024-10-22

High Dose Flu Vaccine in Treating Children Who Have Undergone Donor Stem Cell Transplant

Phase 2 Completed

170 enrolled 11 charts

Influenza, Human, Neoplasms

NCT03061955 2024-10-04

Safety and Efficacy of Concurrent Administration of Influenza Vaccine in Patients Undergoing Anti-PD-1 Immunotherapy (Nivolumab, Pembrolizumab)

Completed

28 enrolled

Influenza, Human, Neoplasms

NCT05116917 2024-05-28

INFLUENCE

Phase 2 Terminated

19 enrolled

Gastrointestinal

Influenza, Human, Pancreatic Neoplasms

NCT01949129 2024-01-16

Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia

Phase 2/3 Recruiting

1,800 enrolled

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05909423 2023-06-18

FLU-IMMUNE

Phase 2 Not yet recruiting

21 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT04484532 2023-06-06

Evaluation of Antibody Response to High-Dose Seasonal Influenza Vaccination in Patients With Myeloid Malignancy Receiving Chemotherapy and Healthy Volunteers

Phase EARLY_PHASE1 Completed

130 enrolled

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT05322330 2023-02-09

Clinical Study of XPO-1 Inhibitors Plus CAR-T Cells in Relapsed Refractory B-cell Non-Hodgkin's Lymphoma

Phase 2 Unknown

20 enrolled

Lymphoid

Lymphoma, B-Cell

NCT02998736 2022-12-28

PERIOP-04

Phase 1 Completed

28 enrolled

Abdominal Cancer

NCT04591379 2022-12-13

Intratumoral Influenza Vaccine for Early Colorectal Cancer

Phase 2 Completed

10 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT02747407 2021-10-29

Qualitative, Qualitative, and Functional Studies Over the First Year in Measuring Immune System Response During the First Year of Therapy in Patients With Brain Tumors

Completed

55 enrolled

CNS

Astrocytoma, Glioma, Oligodendroglioma

NCT04221971 2020-10-01

NK Cell Infusion for Patients With Acute Myeloid Leukemia

Phase 1 Unknown

10 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT04355806 2020-04-21

Impact of Inactivated Trivalent Influenza Vaccine on NSCLC Patients Receiving PD-1 / PD-L1 Inhibitors

Unknown

160 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Influenza, Human

NCT01561989 2020-03-10

Cholecalciferol and Flu Vaccine in Treating Healthy Participants

Phase NA Terminated

11 enrolled 2 charts

Healthy, no Evidence of Disease

NCT03590808 2019-09-19

Influenza Vaccination in Patients Receiving Immune Checkpoint Inhibitor

Phase NA Completed

143 enrolled

Influenza, Human

NCT02566265 2019-01-30

SHIVERING 2

Phase 2 Completed

122 enrolled 10 charts

LymphoidPlasma cell

Influenza, Human, Waldenstrom Macroglobulinemia, Multiple Myeloma

NCT01695733 2018-08-31

Response to Influenza Vaccine in Patients With Non-Hematologic Malignancies Receiving Chemotherapy

Phase 1 Terminated

21 enrolled

Tumor-Agnostic

Neoplasms

NCT01941758 2018-07-05

High-Dose Trivalent Influenza Vaccine in Inducing Immune Response Patients With Central Nervous System Tumors

Phase 1 Completed

28 enrolled

CNS

Central Nervous System Neoplasms

NCT01135329 2018-07-03

Reduced-intensity, Related-donor Bone Marrow Transplantation Followed by High-dose Cyclophosphamide for Hematologic Cancers

Phase 2 Terminated

15 enrolled 8 charts

LymphoidMyeloidOther hematologic neoplasm

Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01474174 2018-07-03

Trivalent Influenza Vaccine in Preventing Flu in Patients With Central Nervous System Tumors

Completed

38 enrolled

CNS

Central Nervous System Neoplasms

NCT01215981 2017-12-28

Influenza Vaccine Post Allogeneic Transplant

Phase NA Terminated

68 enrolled 6 charts

Other hematologic neoplasm

Influenza, Human, Hematologic Neoplasms

NCT00596336 2017-04-12

CLLIFVAC

Phase 2 Terminated

24 enrolled

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT01205581 2016-09-23

Immunogenicity of Fluzone HD,A High Dose Influenza Vaccine, In Children With Cancer or HIV

Phase 2 Completed

85 enrolled 24 charts

Influenza, Human, Neoplasms

NCT01666782 2016-06-24

IMMUNE

Phase 2 Completed

105 enrolled 10 charts

Influenza, Human, Neoplasms

NCT01698177 2013-04-19

Optimizing Influenza Vaccination in Surgical Oncology Patients

Phase 4 Unknown

204 enrolled

Influenza, Human, Neoplasms

NCT00022035 2013-01-31

Vaccine Therapy in Preventing Flu in Children With Acute Lymphoblastic Leukemia

Phase NA Completed

Other hematologic neoplasm

Infections, Leukemia

NCT00979381 2010-03-18

Study of the Immunoresponse in Patients Treated With a Tyrosine Kinase Inhibitor

Completed

75 enrolled

Genitourinary

Carcinoma, Renal Cell

NCT01046227 2010-01-11

Antibody Titer Analysis After H1N1 Vaccination in Pediatric Haemato-oncology Patients

Unknown

50 enrolled

Serology Analysis

Clinical Trials

Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma

Evaluation of Human Immune Responses Vaccination in Patients With Lymphoma

Ibrutinib as an Immune Modulating Agent for Patients With Asymptomatic, High-risk CLL/SLL Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

VRiC

Umbilical Cord Blood Transplantation From Unrelated Donors

A Phase 0 Window of Opportunity Trial of Intratumoral Seasonal Influenza Immunization in Cutaneous Squamous Cell Carcinoma (CSCC) Patients Awaiting Curative Excision

VEN+DAC+Bu2Flu4 vs Bu2Flu5 Conditioning Regimen for Elderly Myeloid Malignancies Undergoing Allo-HSCT

VSMART

BENEFIT-C

Influenza Vaccination for Flu Prevention in Patients With Plasma Cell Disorders

High Dose Flu Vaccine in Treating Children Who Have Undergone Donor Stem Cell Transplant

Safety and Efficacy of Concurrent Administration of Influenza Vaccine in Patients Undergoing Anti-PD-1 Immunotherapy (Nivolumab, Pembrolizumab)

INFLUENCE

Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia

FLU-IMMUNE

Evaluation of Antibody Response to High-Dose Seasonal Influenza Vaccination in Patients With Myeloid Malignancy Receiving Chemotherapy and Healthy Volunteers

Clinical Study of XPO-1 Inhibitors Plus CAR-T Cells in Relapsed Refractory B-cell Non-Hodgkin's Lymphoma

PERIOP-04

Intratumoral Influenza Vaccine for Early Colorectal Cancer

Qualitative, Qualitative, and Functional Studies Over the First Year in Measuring Immune System Response During the First Year of Therapy in Patients With Brain Tumors

NK Cell Infusion for Patients With Acute Myeloid Leukemia

Impact of Inactivated Trivalent Influenza Vaccine on NSCLC Patients Receiving PD-1 / PD-L1 Inhibitors

Cholecalciferol and Flu Vaccine in Treating Healthy Participants

Influenza Vaccination in Patients Receiving Immune Checkpoint Inhibitor

SHIVERING 2

Response to Influenza Vaccine in Patients With Non-Hematologic Malignancies Receiving Chemotherapy

High-Dose Trivalent Influenza Vaccine in Inducing Immune Response Patients With Central Nervous System Tumors

Reduced-intensity, Related-donor Bone Marrow Transplantation Followed by High-dose Cyclophosphamide for Hematologic Cancers

Trivalent Influenza Vaccine in Preventing Flu in Patients With Central Nervous System Tumors

Influenza Vaccine Post Allogeneic Transplant

CLLIFVAC

Immunogenicity of Fluzone HD,A High Dose Influenza Vaccine, In Children With Cancer or HIV

IMMUNE

Optimizing Influenza Vaccination in Surgical Oncology Patients

Vaccine Therapy in Preventing Flu in Children With Acute Lymphoblastic Leukemia

Study of the Immunoresponse in Patients Treated With a Tyrosine Kinase Inhibitor

Antibody Titer Analysis After H1N1 Vaccination in Pediatric Haemato-oncology Patients